Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4)

International Journal of Neuropsychopharmacology

Volumn 10, Issue 2, 2007, Pages 285-289

  Zwanzger, Peter ^a   Eser, Daniela ^a   Völkel, Nikolas ^a   Baghai, Thomas C ^a   Möller, Hans Jürgen ^a   Rupprecht, Rainer ^a   Padberg, Frank ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anxiety; CCK 4; HPA system; Panic; Transcranial magnetic stimulation

Indexed keywords

ALPRAZOLAM; CORTICOTROPIN; HYDROCORTISONE; TETRAGASTRIN;

ADULT; ANALYSIS OF VARIANCE; ANXIETY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS ADRENAL SYSTEM; MALE; NORMAL HUMAN; PANIC; PREFRONTAL CORTEX; PRIORITY JOURNAL; RANDOMIZATION; RATING SCALE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADRENOCORTICOTROPIC HORMONE; ADULT; ALPRAZOLAM; ANTI-ANXIETY AGENTS; AREA UNDER CURVE; FEMALE; HEART RATE; HUMANS; HYDROCORTISONE; MALE; PANIC DISORDER; PSYCHIATRIC STATUS RATING SCALES; TETRAGASTRIN; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 33847024551     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S146114570600695X     Document Type: Article

References (28)

1. Bradwejn J, Koszycki D (1994). Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients. American Journal of Psychiatry 151, 261-263.
2. Bradwejn J, Koszycki D (2001). Cholecystokinin and panic disorder: past and future clinical research strategies. Scandinavian Journal of Clinical and Laboratory Investigation Suppl. 234, 19-27.
3. Chen R, Gerloff C, Hallett M, Cohen LG (1997). Involvement of the ipsilateral motor cortex in finger movements of different complexities. Annals of Neurology 41, 247-254.
4. Cohen H, Kaplan Z, Kotler M, Kouperman I, Moisa R, Grisaru N (2004). Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebocontrolled study. American Journal of Psychiatry 161, 515-524.
5. Garcia-Toro M, Salva CJ, Crespi FM, Andres TJ, Aguirre OI, Bosch CC (2002). Panic disorder and transcranial magnetic stimulation [in Spanish]. Actas Españolas de Psiquiatría 30, 221-224.
6. George MS, Lisanby SH, Sackeim HA (1999). Transcranial magnetic stimulation: applications in neuropsychiatry. Archives of General Psychiatry 56, 300-311.
7. Gorman JM, Kent JM, Sullivan GM, Coplan JD (2000). Neuroanatomical hypothesis of panic disorder, revised. American Journal of Psychiatry 157, 493-505.
8. Grisaru N, Amir M, Cohen H, Kaplan Z (1998). Effect of transcranial magnetic stimulation in posttraumatic stress disorder: a preliminary study. Biological Psychiatry 44, 52-55.
9. Grisaru N, Bruno R, Pridmore S (2001). Effect on the emotions of healthy individuals of slow repetitive transcranial magnetic stimulation applied to the prefrontal cortex. Journal of ECT 17, 184-189.
10. Herwig U, Schonfeldt-Lecuona C, Wunderlich AP, von Tiesenhausen C, Thielscher A, Walter H, Spitzer M (2001). The navigation of transcranial magnetic stimulation. Psychiatry Research 108, 123-131.
11. Hoffman RE, Hawkins KA, Gueorguieva R, Boutros NN, Rachid F, Carroll K, Krystal JH (2003). Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Archives of General Psychiatry 60, 49-56.
12. Jenkins J, Shajahan PM, Lappin JM, Ebmeier KP (2002). Right and left prefrontal transcranial magnetic stimulation at 1 Hz does not affect mood in healthy volunteers. BMC Psychiatry 2, 1.
13. Keck ME, Engelmann M, Muller MB, Henniger MS, Hermann B, Rupprecht R, Neumann ID, Toschi N, Landgraf R, Post A (2000). Repetitive transcranial magnetic stimulation induces active coping strategies and attenuates the neuroendocrine stress response in rats. Journal of Psychiatric Research 34, 265-276.
14. Klein E, Kreinin I, Chistyakov A, Koren D, Mecz L, Marmur S, Ben Shachar D, Feinsod M (1999). Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. Archives of General Psychiatry 56, 315-320.
15. Kobayashi M, Pascual-Leone A (2003). Transcranial magnetic stimulation in neurology. Lancet Neurology 2, 145-156.
16. Koszycki D, Zacharko RM, Le Melledo JM, Bradwejn J (1998). Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers. Depression & Anxiety 8, 1-7.
17. McCann UD, Kimbrell TA, Morgan CM, Anderson T, Geraci M, Benson BE, Wassermann EM, Willis MW, Post RM (1998). Repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Archives of General Psychiatry 55, 276-279.
18. Mosimann UP, Rihs TA, Engeler J, Fisch H, Schlaepfer TE (2000). Mood effects of repetitive transcranial magnetic stimulation of left prefrontal cortex in healthy volunteers. Psychiatry Research 94, 251-256.
19. Padberg F, Juckel G, Prassl A, Zwanzger P, Mavrogiorgou P, Hegerl U, Hampel H, Moller HJ (2001). Prefrontal cortex modulation of mood and emotionally induced facial expressions: a transcranial magnetic stimulation study. Journal of Neuropsychiatry and Clinical Neuroscience 13, 206-212.
20. Post RM, Kimbrell TA, McCann UD, Dunn RT, Osuch EA, Speer AM, Weiss SR (1999). Repetitive transcranial magnetic stimulation as a neuropsychiatric tool: present status and future potential. Journal of ECT 15, 39-59.
21. Romero JR, Anschel D, Sparing R, Gangitano M, Pascual-Leone A (2002). Subthreshold low frequency repetitive transcranial magnetic stimulation selectively decreases facilitation in the motor cortex. Clinical Neurophysiology 113, 101-107.
22. Schutter DJ, van Honk J, d'Alfonso AA, Postma A, de Haan EH (2001). Effects of slow rTMS at the right dorsolateral prefrontal cortex on EEG asymmetry and mood. Neuroreport 12, 445-447.
23. Shlik J, Aluoja A, Vasar V, Vasar E, Podar T, Bradwejn J (1997). Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder. Journal of Psychiatry and Neuroscience 22, 332-340.
24. Ströhle A, Holsboer F, Rupprecht R (2000). Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder. Neuropsychopharmacology 22, 251-256.
25. Ströhle A, Feller C, Onken M, Godemann F, Heinz A, Dimeo F (2005). The acute antipanic activity of aerobic exercise. American Journal of Psychiatry 162, 2376-78.
26. Wittchen HU, Lachner G, Wunderlich U, Pfister H (1998). Test-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI). Social Psychiatry and Psychiatric Epidemiology 33, 568-578.
27. Zwanzger P, Eser D, Aicher S, Schule C, Baghai TC, Padberg F, Ella R, Moller HJ, Rupprecht R (2003). Effects of alprazolam on cholecystokinin- tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study. Neuropsychopharmacology 28, 979-984.
28. Zwanzger P, Minov C, Ella R, Schule C, Baghai T, Moller HJ, Rupprecht R, Padberg F (2002). Transcranial magnetic stimulation for panic. American Journal of Psychiatry 159, 315-316.